NSE and BIOCON Related Headlines

Feb 29, 2024 09:56AM Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®

Sep 6, 2023 07:00AM Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule

Jul 24, 2023 06:30AM Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept

Jul 3, 2023 12:40PM AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS' HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES

NSE and BIOCON Related Press Releases

Feb 29, 2024 09:56AM Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®

Sep 6, 2023 07:00AM Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule

Jul 24, 2023 06:30AM Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept

Jul 3, 2023 12:40PM AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS' HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES

NSE and BIOCON Related SEC Filings